Press release
Posted on September 25, 2023
InsightAce Analytic Pvt. Ltd. Announces Market Assessment Report “Global Migraine Nasal Spray Market – (By Chemical Type (Nasal Triptans, Dihydroergotamine (DHE), Nonsteroidal Anti-Inflammatory Drugs (NSAID))), By Dosage (5 mg, 10 mg, 20mg, 40mg), By Indication (Common Migraine, Classic Migraine, Cluster Migraine, etc.), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)), Trends, Industry Competitive Analysis, Revenue and 2031 year forecast.”
According to the latest research from InsightAce Analytic, Global Migraine Nasal Spray Market Value in USD 478.79 million in 2022and is expected to reach will reach US$850.09 million by 2031, with a The compound annual growth rate is 6.8% during the forecast period 2023-2031.
Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/2060
Migraine nasal spray can be sprayed into one or both noses, depending on the label. You can quickly and effectively treat migraines with a nasal spray instead of taking pills. In as little as 15 minutes of use, the nasal spray can begin to relieve symptoms of acute migraine attacks. Migraine nasal spray is sprayed directly into the nostrils. Global demand for nasal sprays to treat persistent headaches such as migraines has grown even faster in recent years. The aging population and the rise of sedentary lifestyles are driving demand in the industry.
Demand continues to increase due to factors such as increasing awareness and acceptance of treatment management mechanisms, improvements in treatment protocols, and the pursuit of efficiency and accuracy. The market expansion can be partly attributed to the FDA’s approval of nasal spray treatment for migraine. Increased public knowledge also plays a vital role in moving the market forward. However, the expansion of the intranasal migraine drug market may be hampered by the fact that consumers may not be aware of other options for treating lung contamination.
List of prominent players in the Migraine Nasal Spray market:
- Advancing Neuropharmaceuticals
- reddy labs
- Aegis Therapeutics LLC
- Cipra
- Pfizer
- Lockhart Ltd.
- Tonix Pharmaceuticals
- AstraZeneca
- Upshur Smith Laboratory
- AdvaCare Pharmaceuticals
- Roche
- Dickinson Company
- Sanofi
- Novartis
- Merck
- Baxter International Corporation
- becton dickinson co.
- GSK
- Altis Pharmaceuticals
Market dynamics:
driver-
The growing demand for migraine nasal sprays is driven by immediate pain relief, which is the major factor driving the migraine nasal spray market. Since the drug enters the bloodstream directly, first-pass metabolism by the digestive system and liver is avoided. As a result, more medications are now available to treat migraines. As the prevalence of chronic sinusitis has increased over the past few years, so has the potential growth of the nasal sprays for migraine relief market.
As healthcare technology advances, we can expect a greater need for nasal medications. Migraine medications are in high demand around the world as more and more people are learning about the disease and its treatments. Another benefit of using a nasal spray to relieve migraines and nausea is that you don’t have to swallow the medication.
challenge:
The major challenges are lack of familiarity with alternative methods, stringent regulation, and adverse consequences market of drugs due to lockdowns and quarantines in emerging countries, which is expected to slow down the growth of the migraine nasal spray market. However, several unfavorable circumstances for anti-headache nasal sprays severely restrict market expansion. Medication side effects can be debilitating and reduce need. These symptoms include chest pain, dizziness, fatigue and irregular pulse. Companies producing intranasal migraine medications may face difficulties if consumers are unaware of the options available to treat lung contamination.
Regional trends:
North America migraine nasal spray market is expected to account for major market share in terms of revenue. The region is expected to grow at a high CAGR in the near future owing to its production of migraine nasal spray and the industry is investing heavily in R&D to enhance the effectiveness of pharmacies. Increased innovation in the pharmaceutical industry and rising public awareness about mental health have led to rising demand for migraine nasal spray in North America.
Furthermore, nasal sprays are becoming increasingly popular owing to increasing product availability and consumer interest, with Europe holding a sizeable market share. Furthermore, the presence of significant market players and increasing collaboration among key players for market penetration in this domain provides opportunities for growth of the global migraine nasal spray market.
Curious about the latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2060
Recent developments:
- March 2023Pfizer’s Announcement on the Approval of ZAVZPRET
(zavegepant) is approved by the U.S. Food and Drug Administration (FDA). This nasal spray is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist licensed for the immediate treatment of migraine in adults, with or without aura.
- March 2021, the US FDA has approved Cipla’s latest drug, Sumatriptan nasal spray, which is designed to treat migraines. The most recently authorized drug is a generic equivalent treatment of GlaxoSmithKline’s Imitrex nasal spray.
Migraine Nasal Spray Market Segmentation-
go through Chemical type –
- Nasal triptans
- Dihydroergotamine (DHE)
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
By dose –
Follow the instructions –
- Common migraines
- classic migraine
- Migraine cluster
- others
By Distribution Channel-
- hospital pharmacy
- retail pharmacy
- online pharmacy
By Region-
North America-
Europe-
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East and Africa –
- gulf cooperation council countries
- South Africa
- Middle East and Rest of Africa
For more customization@ https://www.insightaceanalytic.com/report/migraine-nasal-spray-market/2060
about Us:
InsightAce Analytic is a market research and consulting firm that helps clients make strategic decisions. Our qualitative and quantitative market intelligence solutions address the market and competitive intelligence needs you need when scaling your business. We help clients gain competitive advantage by identifying untapped markets, exploring new and competitive technologies, segmenting potential markets, and repositioning products. Our expertise is the timely and cost-effective delivery of syndicated and customized market intelligence reports with in-depth analysis with key market insights.
contact us:
InsightAce Analytics Pte Ltd
Phone: +1 718 593 4405
e-mail: (email protected)
On-site visit: www.insightaceanalytic.com
Follow us on LinkedIn @bit.ly/2tBXsgS
Follow us on Facebook @bit.ly/2H9jnDZ